Three Cases of Activation of Cutaneous Squamous-cell Carcinoma During Treatment with Prolonged Administration of Rituximab
- 1 March 2006
- journal article
- Published by Elsevier BV in Clinical Oncology
- Vol. 18 (2), 155-156
- https://doi.org/10.1016/j.clon.2005.11.015
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Reactivation of hepatitis B virus with rituximabExpert Opinion on Drug Safety, 2005
- Rituximab (Rituxan®/MabThera®): the first decade (1993–2003)Expert Review of Anticancer Therapy, 2003
- Delayed‐onset neutropenia associated with rituximab therapyBritish Journal of Haematology, 2003
- Skin cancer and non-Hodgkin's lymphoma as second malignanciesEuropean Journal Of Cancer, 2003
- Rituximab: Mechanism of action and resistanceSeminars in Oncology, 2002
- Rituximab (MabtheraTM, RituxanTM) in Patients with Recurrent Indolent LymphomaMedical Oncology, 2001